BRL29060A (Paroxetine Hydrochloride Hydrate) in Posttraumatic Stress Disorder
Status:
Completed
Trial end date:
2005-06-01
Target enrollment:
Participant gender:
Summary
This was a 52-week, non-comparative, uncontrolled study of paroxetine in Japanese PTSD
patients to obtain clinical experience regarding efficacy and safety. In this study, subjects
received paroxetine 20mg-40mg once daily after an evening meal.